CIK 0001488039 · Non-accelerated filer<br>Smaller reporting company
ATOSSA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATOS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264753208
- Phone
- 206.588.0256
- Business address
- 1448 NW MARKET STREET, SUITE 500, SEATTLE, WA, 98107
- Former names
- ATOSSA GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-15 | Cigler Tessa Director | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2025-05-15 | Steinhart Richard I Director | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2025-03-26 | Remmel H. Lawrence Director | Purchase | +10,000 | $0.70 | $7K | 10,257 |
| 2024-06-27 | Finn Jonathan Director | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2024-06-27 | Steinhart Richard I Director | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2024-06-27 | Remmel H. Lawrence Director | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2024-06-27 | Chen Shu-Chih Director | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2024-06-27 | Rees Heather SVP, Finance and Accounting | Grant or award · Stock Option (right to buy) | +577,700 | 577,700 | ||
| 2024-06-27 | QUAY STEVEN C President & CEO | Grant or award · Stock Option (right to buy) | +1,795,100 | 1,795,100 | ||
| 2024-06-27 | Galli Stephen J Director | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2024-06-27 | Cigler Tessa Director | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2024-04-10 | Finn Jonathan Director | Purchase | +25,000 | $1.77 | $44K | 25,000 |
| 2024-03-09 | Cigler Tessa Director | Grant or award · Stock Option (right to buy) | +20,834 | 20,834 | ||
| 2023-11-15 | WEAVER GREGORY L Former EVP, CFO, & Director | Sale | −50,000 | $0.65 | $33K | 55 |
| 2023-11-15 | Finn Jonathan Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2023-11-15 | Finn Jonathan Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2023-06-20 | WEAVER GREGORY L EVP & CFO | Purchase | +50,000 | $0.97 | $49K | 50,055 |
| 2023-06-01 | WEAVER GREGORY L EVP & CFO | Grant or award · Stock Option (right to buy) | +2,600,000 | 2,600,000 | ||
| 2023-05-04 | WEAVER GREGORY L Director | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2023-05-04 | Remmel H. Lawrence Director | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 |
Page 2 of 9 · 168 trades